Rem Sleep Behavior Disorder: Parasomnia Or Something Else?

REM sleep behaviour disorder (RBD) is a parasomnia characterised by a loss of muscle paralysis during REM sleep, which results in people acting out their dreams. The paralysis that normally occurs during REM sleep is absent or incomplete in people with RBD, allowing them to physically act out their dreams. RBD is marked by the acting out of vivid, intense, and violent dreams through behaviours such as talking, yelling, punching, kicking, jumping out of bed, and more. The person with RBD may wake up during the episode and vividly recall the dream that corresponds to their physical activity. RBD is usually observed in middle-aged to elderly people and is more common in men.

REM sleep behaviour disorder (RBD) is characterised by a loss of muscle paralysis during REM sleep

REM sleep behaviour disorder (RBD) is characterised by a loss of muscle paralysis during the REM phase of sleep. During normal REM sleep, the body's muscles are temporarily paralysed, which is known as muscle atonia or REM atonia. This prevents sleepers from acting out their dreams physically. However, in people with RBD, this paralysis is incomplete or absent, allowing them to act out their dreams, which are often vivid, intense, and violent.

The loss of muscle paralysis during REM sleep in people with RBD can cause them to engage in a range of physical movements and actions, such as talking, yelling, punching, kicking, sitting up, jumping out of bed, and flailing their arms. These behaviours can result in injuries to themselves or their bed partners. The risk of violent movements and injuries is higher if the person is having an aggressive or frightening dream.

The frequency of motor events in people with RBD can vary from multiple episodes per night to one episode per month, and the severity and frequency of behaviours can also differ from night to night and over the course of the condition. While the exact cause of RBD is unknown, it is often associated with degenerative neurological conditions such as Parkinson's disease, multisystem atrophy, and Lewy body dementia. It is also linked to certain medications, including antidepressants and alcohol or sedative-hypnotic drug withdrawal.

The diagnosis of RBD typically involves a clinical assessment and an overnight video polysomnography (v-PSG) study, which includes monitoring of brain activity, muscle activity, respiratory function, and heart rate, as well as video recording of the patient during sleep. Treatment for RBD focuses on creating a safe sleeping environment and may include medications such as clonazepam and melatonin.

RBD is associated with acting out dreams through physical and vocal behaviours

REM sleep behaviour disorder (RBD) is a parasomnia in which a person physically and vocally acts out their dreams during the REM stage of sleep. During REM sleep, the body usually experiences muscle atonia (paralysis), but for people with RBD, this paralysis is incomplete or absent, allowing them to act out their dreams.

The acting out of dreams typically involves abnormal vocalisations and abnormal motor behaviour, such as talking, yelling, punching, kicking, jumping from bed, arm flailing, and grabbing. These behaviours can be violent and lead to injuries to oneself or one's bed partner. People with RBD are often unaware of their actions and only find out about their condition when their bed partner informs them or when they wake up with an injury.

Upon awakening, people with RBD can typically recall the content of their dreams, which are often vivid, intense, and violent. The symptoms of RBD can vary in severity, ranging from mild muscle twitches to more complex and violent movements. Episodes can occur once or multiple times during a sleeping period and tend to be more severe when acting out a violent nightmare.

RBD is usually seen in middle-aged to elderly people, with a higher prevalence in men. It is estimated to affect about 1% of the general population and 2% of people aged 50 or older. The exact cause of RBD is unknown, but it is often associated with neurodegenerative disorders, such as Parkinson's disease, Lewy body dementia, and multiple system atrophy.

RBD is more common in men and adults over 50

REM sleep behaviour disorder (RBD) is a parasomnia, a sleep disorder that involves unusual and undesirable physical events or experiences that disrupt sleep. It occurs when the temporary paralysis that normally occurs during REM sleep is incomplete or absent, allowing the person to act out their dreams. RBD is more common in men and adults over 50.

RBD is more prevalent in men, with one source stating that men are nine times more likely to have RBD than women. This gender disparity is less pronounced in adults under 50 with RBD, where there is more gender parity, with one source reporting 55-59% of cases occurring in men.

RBD is also more common in older adults, with the average age of onset being 61. While it can affect children and younger adults, this is considered rare.

The reasons for the higher prevalence of RBD in men are unclear, but it may be due in part to the higher rate of antidepressant usage in women, which has been linked to RBD. Additionally, the increased prevalence of RBD in older adults may be because RBD often occurs several years before the development of neurodegenerative diseases such as Parkinson's disease, which are more common in older adults.

RBD is linked to neurodegenerative diseases such as Parkinson's and dementia

REM sleep behaviour disorder (RBD) is a parasomnia characterised by excessive muscle activity during REM sleep, typically associated with unpleasant dreams and dream enactment behaviour. RBD is generally considered to be associated with synucleinopathies, such as Parkinson's disease, Lewy body dementia, and multiple system atrophy. However, it has also been found in non-synucleinopathy neurodegenerative diseases, including Alzheimer's disease, Huntington's disease, and amyotrophic lateral sclerosis.

RBD is believed to predict neurodegeneration in synucleinopathy and may be used as an early marker of neurodegenerative diseases. The occurrence of RBD in the general population is estimated to be between 0.38% and 2.01%, but the prevalence is much higher in patients with neurodegenerative diseases, especially synucleinopathies. In one study, 38% of people diagnosed with RBD developed Parkinson's disease within an average of 12 to 13 years after the onset of RBD symptoms. Another study found that almost half of Parkinson's disease patients, at least 88% of multiple system atrophy patients, and about 80% of Lewy body dementia patients have RBD. Furthermore, up to 98% of individuals with polysomnography-confirmed RBD have synucleinopathy.

The link between RBD and neurodegenerative diseases is not fully understood. However, it is believed that the degeneration of glycinergic and GABA-ergic neurons in specific brain regions may play a role in the pathogenesis of RBD. Additionally, there is evidence that RBD may be triggered by neurodegenerative diseases or associated with antidepressant treatments, alcohol, and drug withdrawal.

The treatment of RBD focuses on ensuring the safety of the patient and their bed partner, and pharmacological interventions may be considered. Clonazepam is often the first-line drug to improve symptoms, while melatonin and pramipexole are also used. It is important to carefully monitor patients taking these medications, especially those with advanced disease and a higher risk of falls and cognitive impairment.

Diagnosis of RBD is confirmed by a sleep study and treatment focuses on safety and medication

REM sleep behaviour disorder (RBD) is a parasomnia characterised by dream enactment and the disruption of physiological muscle atonia during REM sleep. Diagnosis of RBD is confirmed by a sleep study, specifically a video polysomnography or polysomnogram (PSG). This involves an in-lab video sleep study that records specific body functions during sleep, such as breathing rate and airflow, brain wave activity, and muscle movements of the chin and upper extremities.

The International Classification of Sleep Disorders outlines the following criteria for an RBD diagnosis:

• Repeated episodes of sleep-related vocalisation and/or complex movement behaviours.
• These behaviours are documented by polysomnography to occur during REM sleep or are presumed to occur during REM sleep based on clinical history.
• Polysomnographic recording demonstrates REM sleep without atonia (RWA).
• The disturbance is not better explained by another sleep disorder, mental disorder, medication, or substance abuse.

Treatment for RBD focuses on safety and medication. The main goal is to create a safe sleeping environment for the patient and their bed partner. This includes removing sharp objects and heavy objects from the bedroom, placing pillows around the bed, and sleeping on a mattress on the floor to prevent injury from falling out of bed.

If safety measures are insufficient to prevent injury, medication may be prescribed to manage symptoms. Melatonin, a natural hormone essential for regulating the sleep cycle, is typically the first line of medication. If this is ineffective, clonazepam, a sedative, may be prescribed, although this can cause unpleasant side effects. Pramipexole, a dopamine agonist, has also been found to help treat RBD symptoms.

Frequently asked questions